A citation-based method for searching scientific literature

Michelle L O'Donoghue, Ruchira Glaser, Matthew A Cavender, Philip E Aylward, Marc P Bonaca, Andrzej Budaj, Richard Y Davies, Mikael Dellborg, Keith A A Fox, Jorge Antonio T Gutierrez, Christian Hamm, Robert G Kiss, František Kovar, Julia F Kuder, Kyung Ah Im, John J Lepore, Jose L Lopez-Sendon, Ton Oude Ophuis, Alexandr Parkhomenko, Jennifer B Shannon, Jindrich Spinar, Jean-Francois Tanguay, Mikhail Ruda, P Gabriel Steg, Pierre Theroux, Stephen D Wiviott, Ian Laws, Marc S Sabatine, David A Morrow. JAMA 2016
Times Cited: 147







List of co-cited articles
1016 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Paul M Ridker, Brendan M Everett, Tom Thuren, Jean G MacFadyen, William H Chang, Christie Ballantyne, Francisco Fonseca, Jose Nicolau, Wolfgang Koenig, Stefan D Anker,[...]. N Engl J Med 2017
66

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Paul M Ridker, Brendan M Everett, Aruna Pradhan, Jean G MacFadyen, Daniel H Solomon, Elaine Zaharris, Virak Mam, Ahmed Hasan, Yves Rosenberg, Erin Iturriaga,[...]. N Engl J Med 2019
550
47

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.
Michelle L O'Donoghue, Eugene Braunwald, Harvey D White, Mary Ann Lukas, Elizabeth Tarka, P Gabriel Steg, Judith S Hochman, Christoph Bode, Aldo P Maggioni, KyungAh Im,[...]. JAMA 2014
292
41

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
Jean-Claude Tardif, Simon Kouz, David D Waters, Olivier F Bertrand, Rafael Diaz, Aldo P Maggioni, Fausto J Pinto, Reda Ibrahim, Habib Gamra, Ghassan S Kiwan,[...]. N Engl J Med 2019
872
40

Low-dose colchicine for secondary prevention of cardiovascular disease.
Stefan M Nidorf, John W Eikelboom, Charley A Budgeon, Peter L Thompson. J Am Coll Cardiol 2013
479
37

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.
Stephen J Nicholls, John J P Kastelein, Gregory G Schwartz, Dianna Bash, Robert S Rosenson, Matthew A Cavender, Danielle M Brennan, Wolfgang Koenig, J Wouter Jukema, Vijay Nambi,[...]. JAMA 2014
201
28

Darapladib for preventing ischemic events in stable coronary heart disease.
Harvey D White, Claes Held, Ralph Stewart, Elizabeth Tarka, Rebekkah Brown, Richard Y Davies, Andrzej Budaj, Robert A Harrington, P Gabriel Steg, Diego Ardissino,[...]. N Engl J Med 2014
358
27

Colchicine in Patients with Chronic Coronary Disease.
Stefan M Nidorf, Aernoud T L Fiolet, Arend Mosterd, John W Eikelboom, Astrid Schut, Tjerk S J Opstal, Salem H K The, Xiao-Fang Xu, Mark A Ireland, Timo Lenderink,[...]. N Engl J Med 2020
419
27

Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial.
L Kristin Newby, Michael S Marber, Chiara Melloni, Lea Sarov-Blat, Laura H Aberle, Philip E Aylward, Gengqian Cai, Robbert J de Winter, Christian W Hamm, John F Heitner,[...]. Lancet 2014
101
24

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
Peter Duewell, Hajime Kono, Katey J Rayner, Cherilyn M Sirois, Gregory Vladimer, Franz G Bauernfeind, George S Abela, Luigi Franchi, Gabriel Nuñez, Max Schnurr,[...]. Nature 2010
22


Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Paul M Ridker, Eleanor Danielson, Francisco A H Fonseca, Jacques Genest, Antonio M Gotto, John J P Kastelein, Wolfgang Koenig, Peter Libby, Alberto J Lorenzatti, Jean G MacFadyen,[...]. N Engl J Med 2008
20

Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).
Paul M Ridker, Peter Libby, Jean G MacFadyen, Tom Thuren, Christie Ballantyne, Francisco Fonseca, Wolfgang Koenig, Hiroaki Shimokawa, Brendan M Everett, Robert J Glynn. Eur Heart J 2018
231
19

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.
Daniel I Swerdlow, Michael V Holmes, Karoline B Kuchenbaecker, Jorgen E L Engmann, Tina Shah, Reecha Sofat, Yiran Guo, Christina Chung, Anne Peasey, Roman Pfister,[...]. Lancet 2012
644
18

The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study.
Allison C Morton, Alexander M K Rothman, John P Greenwood, Julian Gunn, Alex Chase, Bernard Clarke, Alistair S Hall, Keith Fox, Claire Foley, Winston Banya,[...]. Eur Heart J 2015
174
18

Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial.
Ola Kleveland, Gabor Kunszt, Marte Bratlie, Thor Ueland, Kaspar Broch, Espen Holte, Annika E Michelsen, Bjørn Bendz, Brage H Amundsen, Terje Espevik,[...]. Eur Heart J 2016
172
18

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies.
Nadeem Sarwar, Adam S Butterworth, Daniel F Freitag, John Gregson, Peter Willeit, Donal N Gorman, Pei Gao, Danish Saleheen, Augusto Rendon, Christopher P Nelson,[...]. Lancet 2012
507
16

Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease.
Renata Micha, Fumiaki Imamura, Moritz Wyler von Ballmoos, Daniel H Solomon, Miguel A Hernán, Paul M Ridker, Dariush Mozaffarian. Am J Cardiol 2011
338
15

Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial.
Jean-Claude Tardif, Jean-François Tanguay, Scott R Wright, Valérie Duchatelle, Thibaut Petroni, Jean C Grégoire, Reda Ibrahim, Therese M Heinonen, Stephen Robb, Olivier F Bertrand,[...]. J Am Coll Cardiol 2013
120
15

Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study.
Kaivan Vaidya, Clare Arnott, Gonzalo J Martínez, Bernard Ng, Samuel McCormack, David R Sullivan, David S Celermajer, Sanjay Patel. JACC Cardiovasc Imaging 2018
121
15

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
Siddhartha Jaiswal, Pradeep Natarajan, Alexander J Silver, Christopher J Gibson, Alexander G Bick, Eugenia Shvartz, Marie McConkey, Namrata Gupta, Stacey Gabriel, Diego Ardissino,[...]. N Engl J Med 2017
972
15

Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome.
Gonzalo J Martínez, Stacy Robertson, Jennifer Barraclough, Qiong Xia, Ziad Mallat, Christina Bursill, David S Celermajer, Sanjay Patel. J Am Heart Assoc 2015
161
14

C-reactive protein levels and outcomes after statin therapy.
Paul M Ridker, Christopher P Cannon, David Morrow, Nader Rifai, Lynda M Rose, Carolyn H McCabe, Marc A Pfeffer, Eugene Braunwald. N Engl J Med 2005
14


Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.
José J Fuster, Susan MacLauchlan, María A Zuriaga, Maya N Polackal, Allison C Ostriker, Raja Chakraborty, Chia-Ling Wu, Soichi Sano, Sujatha Muralidharan, Cristina Rius,[...]. Science 2017
603
13


Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Marc S Sabatine, Robert P Giugliano, Anthony C Keech, Narimon Honarpour, Stephen D Wiviott, Sabina A Murphy, Julia F Kuder, Huei Wang, Thomas Liu, Scott M Wasserman,[...]. N Engl J Med 2017
12

Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction.
Antonio Abbate, Cory R Trankle, Leo F Buckley, Michael J Lipinski, Darryn Appleton, Dinesh Kadariya, Justin M Canada, Salvatore Carbone, Charlotte S Roberts, Nayef Abouzaki,[...]. J Am Heart Assoc 2020
64
18

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
P M Ridker, M Cushman, M J Stampfer, R P Tracy, C H Hennekens. N Engl J Med 1997
11

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial.
Jean-Claude Tardif, John J V McMurray, Eric Klug, Robert Small, Jennifer Schumi, Jasmine Choi, Jim Cooper, Robert Scott, Eldrin F Lewis, Philippe L L'Allier,[...]. Lancet 2008
142
11

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Christopher P Cannon, Michael A Blazing, Robert P Giugliano, Amy McCagg, Jennifer A White, Pierre Theroux, Harald Darius, Basil S Lewis, Ton Oude Ophuis, J Wouter Jukema,[...]. N Engl J Med 2015
10

NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.
Alena Grebe, Florian Hoss, Eicke Latz. Circ Res 2018
282
10

NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
Thomas van der Heijden, Eva Kritikou, Wouter Venema, Janine van Duijn, Peter J van Santbrink, Bram Slütter, Amanda C Foks, Ilze Bot, Johan Kuiper. Arterioscler Thromb Vasc Biol 2017
170
10

The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.
G Liuzzo, L M Biasucci, J R Gallimore, R L Grillo, A G Rebuzzi, M B Pepys, A Maseri. N Engl J Med 1994
10

Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study].
Antonio Abbate, Benjamin Wallace Van Tassell, Giuseppe Biondi-Zoccai, Michael Christopher Kontos, John Dallas Grizzard, Debra Whittaker Spillman, Claudia Oddi, Charlotte Susan Roberts, Ryan David Melchior, George Herman Mueller,[...]. Am J Cardiol 2013
236
10

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Deepak L Bhatt, P Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Craig Granowitz,[...]. N Engl J Med 2019
10

Colchicine--Update on mechanisms of action and therapeutic uses.
Ying Ying Leung, Laura Li Yao Hui, Virginia B Kraus. Semin Arthritis Rheum 2015
330
10

Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial.
David C Tong, Stephen Quinn, Arthur Nasis, Chin Hiew, Philip Roberts-Thomson, Heath Adams, Rumes Sriamareswaran, Nay M Htun, William Wilson, Dion Stub,[...]. Circulation 2020
104
10

Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.
Daria B Crittenden, R Aaron Lehmann, Laura Schneck, Robert T Keenan, Binita Shah, Jeffrey D Greenberg, Bruce N Cronstein, Steven P Sedlis, Michael H Pillinger. J Rheumatol 2012
119
9

Progress and challenges in translating the biology of atherosclerosis.
Peter Libby, Paul M Ridker, Göran K Hansson. Nature 2011
9

Inflammation in atherosclerosis: from pathophysiology to practice.
Peter Libby, Paul M Ridker, Göran K Hansson. J Am Coll Cardiol 2009
9

Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
Erin A Bohula, Robert P Giugliano, Christopher P Cannon, Jing Zhou, Sabina A Murphy, Jennifer A White, Andrew M Tershakovec, Michael A Blazing, Eugene Braunwald. Circulation 2015
191
9


Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis.
Maysoon Elkhawad, James H F Rudd, Lea Sarov-Blat, Gengqian Cai, Richard Wells, L Ceri Davies, David J Collier, Michael S Marber, Robin P Choudhury, Zahi A Fayad,[...]. JACC Cardiovasc Imaging 2012
104
9

Inflammatory and Cholesterol Risk in the FOURIER Trial.
Erin A Bohula, Robert P Giugliano, Lawrence A Leiter, Subodh Verma, Jeong-Gun Park, Peter S Sever, Armando Lira Pineda, Narimon Honarpour, Huei Wang, Sabina A Murphy,[...]. Circulation 2018
125
9

Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.
Antonio Abbate, Stefano Toldo, Carlo Marchetti, Jordana Kron, Benjamin W Van Tassell, Charles A Dinarello. Circ Res 2020
159
9

Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy.
Tjerk S J Opstal, Renate M Hoogeveen, Aernoud T L Fiolet, Max J M Silvis, Salem H K The, Willem A Bax, Dominique P V de Kleijn, Arend Mosterd, Erik S G Stroes, Jan H Cornel. Circulation 2020
50
18

Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial.
Paul M Ridker, Campbell P Howard, Verena Walter, Brendan Everett, Peter Libby, Johannes Hensen, Tom Thuren. Circulation 2012
353
8

Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial.
Michelle L O'Donoghue, Ruchira Glaser, Philip E Aylward, Matthew A Cavender, Adam Crisp, Keith A A Fox, Ian Laws, Jose L Lopez-Sendon, P Gabriel Steg, Pierre Theroux,[...]. Am Heart J 2015
29
27

Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study.
Spyridon Deftereos, Georgios Giannopoulos, Christos Angelidis, Nikolaos Alexopoulos, Gerasimos Filippatos, Nikolaos Papoutsidakis, George Sianos, John Goudevenos, Dimitrios Alexopoulos, Vlasios Pyrgakis,[...]. Circulation 2015
134
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.